Bausch Health Companies | VRX - Operating Expenses



Bausch Health Companies reported $2.07B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Amgen USD 6.52B 337M Jun/2025
ANI Pharmaceuticals USD 196.2M 25.27M Jun/2025
Aurora Cannabis CAD 118.24M 66.26M Jun/2025
Bausch Health Companies USD 2.07B 90M Jun/2025
Biogen USD 1.79B 326.1M Jun/2025
Bristol-Myers Squibb USD 8.5B 265M Jun/2025
Canopy Growth CAD 94.22M 4.36M Jun/2025
Corcept Therapeutics USD 167.76M 13.96M Jun/2025
Danaher USD 5.18B 718M Jun/2025
Drreddys Laboratories INR 68.61B 3.74B Jun/2025
Eli Lilly USD 8.54B 1.22B Jun/2025
Gilead Sciences USD 4.35B 80M Jun/2025
Novo Nordisk 42.77B 3.48B Jun/2025
Pacira USD 170.87M 3.93M Jun/2025
Perrigo USD 1B 36.2M Jun/2025
Prestige Brands USD 177.77M 30.32M Jun/2025
Supernus Pharmaceuticals USD 153.31M 892K Jun/2025
Vertex Pharmaceuticals USD 1.81B 71.4M Jun/2025
Zoetis USD 1.44B 35M Jun/2025